Skip to main content
Erschienen in: Pathology & Oncology Research 3/2014

01.07.2014 | Research

HIF-1α Expression Correlates with Cellular Apoptosis, Angiogenesis and Clinical Prognosis in Rectal Carcinoma

verfasst von: Liu Feng, Lin Tao, He Dawei, Li Xuliang, Luo Xiaodong

Erschienen in: Pathology & Oncology Research | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Regional hypoxia caused by accelerated cell proliferation and overgrowth is an important characteristic of neoplasm. Hypoxia can cause a series of changes in gene transcription and protein expression, thereby not only inducing tumor cell resistance to radiotherapy and chemotherapy but also promoting tumor invasion and metastasis. This study aimed to investigate the relationship between HIF-1α expression and cellular apoptosis, angiogenesis and clinical prognosis in rectal carcinoma. In 113 rectal carcinoma cases, cellular apoptosis was analyzed by the in situ terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) assay, whereas the levels of HIF-1α expression, VEGF expression, microvessel density (MVD) and lymphatic vessel density(LVD) were examined by immunohistochemical staining. HIF-1 expression was detected in 67 of 113 rectal carcinoma cases (59.3 %). A positive correlation was found among HIF-1α expression, cellular apoptosis and angiogenesis. The 5-year survival rate in the HIF-1α-negative group was significantly higher than that in the HIF-1α-positive group (81.34 % versus 50 %, P < 0.05). According to the Cox regression analysis, HIF-1α expression, VEGF expression and cellular apoptosis index were independent risk factors for clinical prognosis in rectal carcinoma. Aberrant HIF-1α expression correlates with apoptosis inhibition, angiogenesis and poor prognosis in rectal carcinoma.
Literatur
1.
Zurück zum Zitat Gupta SC, Kim JH, Prasad S et al (2010) Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 29(3):405–434PubMedCrossRefPubMedCentral Gupta SC, Kim JH, Prasad S et al (2010) Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 29(3):405–434PubMedCrossRefPubMedCentral
2.
Zurück zum Zitat de Krijger I, Mekenkamp LJ, Punt CJ et al (2011) MicroRNAs in colorectal cancer metastasis. J Pathol 224(4):438–447PubMedCrossRef de Krijger I, Mekenkamp LJ, Punt CJ et al (2011) MicroRNAs in colorectal cancer metastasis. J Pathol 224(4):438–447PubMedCrossRef
3.
Zurück zum Zitat Arvelo F, Cotte C (2009) Hypoxia in cancer malignity. Invest Clin 50(4):529–546PubMed Arvelo F, Cotte C (2009) Hypoxia in cancer malignity. Invest Clin 50(4):529–546PubMed
4.
Zurück zum Zitat Greijer AE, van der Groep P, Kemming D et al (2005) Up-regulation of gene expression by hypoxia is medi-ated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol 206:291–304PubMedCrossRef Greijer AE, van der Groep P, Kemming D et al (2005) Up-regulation of gene expression by hypoxia is medi-ated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol 206:291–304PubMedCrossRef
5.
Zurück zum Zitat Belozerov VE, Van Meir EG (2005) Hypoxia inducible factor-1: a novel target for cancer therapy. Anticancer Drugs 16(9):901–909PubMedCrossRef Belozerov VE, Van Meir EG (2005) Hypoxia inducible factor-1: a novel target for cancer therapy. Anticancer Drugs 16(9):901–909PubMedCrossRef
6.
Zurück zum Zitat Mucaj V, Shay JE, Simon MC (2012) Effects of hypoxia and HIFs on cancer metabolism. Int J Hematol 95(5):464–670PubMedCrossRef Mucaj V, Shay JE, Simon MC (2012) Effects of hypoxia and HIFs on cancer metabolism. Int J Hematol 95(5):464–670PubMedCrossRef
7.
Zurück zum Zitat Semenza GL (2000) HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88(4):1474–1480PubMed Semenza GL (2000) HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88(4):1474–1480PubMed
8.
Zurück zum Zitat Yeung SJ, Pan J, Lee MH (2008) Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer. Cell Mol Life Sci 65(24):3981–3999PubMedCrossRef Yeung SJ, Pan J, Lee MH (2008) Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer. Cell Mol Life Sci 65(24):3981–3999PubMedCrossRef
9.
Zurück zum Zitat Rapisarda A, Melillo G (2012) Role of the VEGF/VEGFR axis in cancer biology and therapy. Adv Cancer Res 114:237–267PubMedCrossRef Rapisarda A, Melillo G (2012) Role of the VEGF/VEGFR axis in cancer biology and therapy. Adv Cancer Res 114:237–267PubMedCrossRef
12.
Zurück zum Zitat Menrad H, Werno C, Schmid T et al (2010) Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids. Hepatology 51(6):2183–2192PubMedCrossRef Menrad H, Werno C, Schmid T et al (2010) Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids. Hepatology 51(6):2183–2192PubMedCrossRef
13.
Zurück zum Zitat Ardyanto TD, Osaki M, Nagahama Y et al (2008) Down-regulation of cobalt-induced HIF-1alpha expression correlates with cell proliferation and apoptosis in human gastric carcinoma cells. Oncol Rep 19(2):339–343PubMed Ardyanto TD, Osaki M, Nagahama Y et al (2008) Down-regulation of cobalt-induced HIF-1alpha expression correlates with cell proliferation and apoptosis in human gastric carcinoma cells. Oncol Rep 19(2):339–343PubMed
14.
Zurück zum Zitat Hao X, Du M, Bishop AE et al (1998) Imbalance between proliferation and apoptosis in development of colorectal carcinoma. Virchows Arch 433:523–527PubMedCrossRef Hao X, Du M, Bishop AE et al (1998) Imbalance between proliferation and apoptosis in development of colorectal carcinoma. Virchows Arch 433:523–527PubMedCrossRef
15.
Zurück zum Zitat Benchabane H, Ahmed Y (2009) The adenomatous polyposis coli tumor suppressor and Wnt signaling in the regulation of apoptosis. Adv Exp Med Biol 656:75–84PubMedCrossRefPubMedCentral Benchabane H, Ahmed Y (2009) The adenomatous polyposis coli tumor suppressor and Wnt signaling in the regulation of apoptosis. Adv Exp Med Biol 656:75–84PubMedCrossRefPubMedCentral
16.
Zurück zum Zitat Lampropoulos P, Zizi-Sermpetzoglou A, Rizos S et al (2012) TGF-beta signalling in colon carcinogenesis. Cancer Lett 314(1):1–7PubMedCrossRef Lampropoulos P, Zizi-Sermpetzoglou A, Rizos S et al (2012) TGF-beta signalling in colon carcinogenesis. Cancer Lett 314(1):1–7PubMedCrossRef
17.
Zurück zum Zitat Liu W, Shen SM, Zhao XY et al (2012) Targeted genes and interacting proteins of hypoxia inducible factor-1. Int J Biochem Mol Biol 3(2):165–178PubMedPubMedCentral Liu W, Shen SM, Zhao XY et al (2012) Targeted genes and interacting proteins of hypoxia inducible factor-1. Int J Biochem Mol Biol 3(2):165–178PubMedPubMedCentral
18.
Zurück zum Zitat Zhong H, De Marzo AM, Laughner E et al (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59:5830–5835PubMed Zhong H, De Marzo AM, Laughner E et al (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59:5830–5835PubMed
19.
Zurück zum Zitat Koh MY, Spivak-Kroizman TR, Powis G (2010) HIF-1alpha and cancer therapy. Recent Results Cancer Res 180:15–34PubMedCrossRef Koh MY, Spivak-Kroizman TR, Powis G (2010) HIF-1alpha and cancer therapy. Recent Results Cancer Res 180:15–34PubMedCrossRef
20.
Zurück zum Zitat Simiantonaki N, Taxeidis M, Jayasinghe C et al (2008) Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression. BMC Cancer 8:320PubMedCrossRefPubMedCentral Simiantonaki N, Taxeidis M, Jayasinghe C et al (2008) Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression. BMC Cancer 8:320PubMedCrossRefPubMedCentral
21.
Zurück zum Zitat Kotch LE, Iyer NV, Laughner E et al (1999) Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev Biol 209:254–267PubMedCrossRef Kotch LE, Iyer NV, Laughner E et al (1999) Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev Biol 209:254–267PubMedCrossRef
22.
Zurück zum Zitat Tsuzuki Y, Fukumura D, Oosthuyse B et al (2000) Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha–> hypoxia re-sponse element–> VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res 60:6248–6252PubMed Tsuzuki Y, Fukumura D, Oosthuyse B et al (2000) Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha–> hypoxia re-sponse element–> VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res 60:6248–6252PubMed
23.
Zurück zum Zitat Rey S, Semenza GL (2010) Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res 86(2):236–242PubMedCrossRefPubMedCentral Rey S, Semenza GL (2010) Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res 86(2):236–242PubMedCrossRefPubMedCentral
25.
Zurück zum Zitat Suzuki H, Tomida A, Tsuruo T (2001) Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia. Oncogene 20(41):5779–5788PubMedCrossRef Suzuki H, Tomida A, Tsuruo T (2001) Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia. Oncogene 20(41):5779–5788PubMedCrossRef
26.
Zurück zum Zitat Piret JP, Mottet D, Raes M et al (2002) Is HIF-1alpha a pro- or an anti-apoptotic protein? Biochem Pharmacol 64(5–6):889–892PubMedCrossRef Piret JP, Mottet D, Raes M et al (2002) Is HIF-1alpha a pro- or an anti-apoptotic protein? Biochem Pharmacol 64(5–6):889–892PubMedCrossRef
27.
Zurück zum Zitat Price DJ, Miralem T, Jiang S et al (2001) Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells. Cell Growth Differ 12(3):129–135PubMed Price DJ, Miralem T, Jiang S et al (2001) Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells. Cell Growth Differ 12(3):129–135PubMed
28.
Zurück zum Zitat Bos R, van Diest PJ, van der Groep P et al (2004) Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related. Breast Cancer Res 6(4):R450–R459PubMedCrossRefPubMedCentral Bos R, van Diest PJ, van der Groep P et al (2004) Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related. Breast Cancer Res 6(4):R450–R459PubMedCrossRefPubMedCentral
29.
Zurück zum Zitat Nagy JA, Vasile E, Feng D et al (2002) Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 196(11):1497–1506PubMedCrossRefPubMedCentral Nagy JA, Vasile E, Feng D et al (2002) Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 196(11):1497–1506PubMedCrossRefPubMedCentral
30.
Zurück zum Zitat Mohammed RA, Green A, El-Shikh S et al (2007) Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis. Br J Cancer 96(7):1092–1100PubMedCrossRefPubMedCentral Mohammed RA, Green A, El-Shikh S et al (2007) Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis. Br J Cancer 96(7):1092–1100PubMedCrossRefPubMedCentral
31.
Zurück zum Zitat Gao Y, Zhong WX, Mu DB et al (2008) Distributions of angiogenesis and lymphangiogenesis in gastrointestinal intramucosal tumors. Ann Surg Oncol 15(4):1117–1123PubMedCrossRef Gao Y, Zhong WX, Mu DB et al (2008) Distributions of angiogenesis and lymphangiogenesis in gastrointestinal intramucosal tumors. Ann Surg Oncol 15(4):1117–1123PubMedCrossRef
Metadaten
Titel
HIF-1α Expression Correlates with Cellular Apoptosis, Angiogenesis and Clinical Prognosis in Rectal Carcinoma
verfasst von
Liu Feng
Lin Tao
He Dawei
Li Xuliang
Luo Xiaodong
Publikationsdatum
01.07.2014
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 3/2014
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-013-9738-6

Weitere Artikel der Ausgabe 3/2014

Pathology & Oncology Research 3/2014 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.